Insights

Innovative Technological Focus HippoFi leverages advanced digital, biological technologies, and intelligent automation across its segments, presenting opportunities to offer cutting-edge medical equipment, AI-driven healthcare solutions, and fintech integrations tailored to their innovative approach.

Strategic Growth in Regenerative Medicine The company's recent acquisitions and leadership hires in regenerative therapeutics indicate a focus on expanding biologic and cell-based therapies, creating potential sales avenues for biotech products, regenerative devices, and personalized treatment solutions.

Partnership and Collaborations HippoFi's recent partnership with Zimmer Biomet and various product launches suggest openness to strategic alliances, providing a pathway to collaborate on new spine surgery technologies, biologics, and innovative medical devices across orthopedics and regenerative markets.

Market Expansion Opportunities With a focus on spinal biologics, regenerative therapeutics, and biologic products, there are substantial opportunities to introduce complementary medical equipment, biologic supplies, and clinical solutions to support the company's growing product portfolio.

Emerging Revenue Streams Despite current revenue levels, HippoFi's launch of new products and strategic partnerships indicate potential future sales growth, especially in regenerative medicine and biotech sectors, making it a promising target for innovative medical technology offerings.

HippoFi (Formerly ORHub, Inc.) Email Formats	Example	Percentage
First.Last@orhub.com	John.Doe@orhub.com	72%
First@orhub.com	John@orhub.com	11%
FirstLast@orhub.com	JohnDoe@orhub.com	11%
Fir.Last@orhub.com	Joh.Doe@orhub.com	6%

HippoFi (Formerly ORHub, Inc.) Email Formats

Example

Percentage

First.Last@orhub.com

John.Doe@orhub.com

72%

First@orhub.com

John@orhub.com

11%

FirstLast@orhub.com

JohnDoe@orhub.com

11%

Fir.Last@orhub.com

Joh.Doe@orhub.com

Frequently Asked Questions

Where is HippoFi (Formerly ORHub, Inc.)'s headquarters located?

HippoFi (Formerly ORHub, Inc.)'s main headquarters is located at 9180 Irvine Center Drive Irvine, California 92618 United States. The company has employees across 1 continents, including North America.

What is HippoFi (Formerly ORHub, Inc.)'s stock symbol?

HippoFi (Formerly ORHub, Inc.) is a publicly traded company; the company's stock symbol is ORHB.

What is HippoFi (Formerly ORHub, Inc.)'s official website and social media links?

HippoFi (Formerly ORHub, Inc.)'s official website is hippofi.com and has social profiles on LinkedIn.

What is HippoFi (Formerly ORHub, Inc.)'s NAICS code?

HippoFi (Formerly ORHub, Inc.)'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does HippoFi (Formerly ORHub, Inc.) have currently?

As of April 2026, HippoFi (Formerly ORHub, Inc.) has approximately 4 employees across 1 continents, including North America. Key team members include Head Of Pur Biologics: R. F.Founder, Executive Chairman, President & Ceo: C. W.Interim Chief Financial Officer: B. M.. Explore HippoFi (Formerly ORHub, Inc.)'s employee directory with LeadIQ.

What industry does HippoFi (Formerly ORHub, Inc.) belong to?

HippoFi (Formerly ORHub, Inc.) operates in the Medical Equipment Manufacturing industry.

What is HippoFi (Formerly ORHub, Inc.)'s email format?

HippoFi (Formerly ORHub, Inc.)'s email format typically follows the pattern of First.Last@orhub.com. Find more HippoFi (Formerly ORHub, Inc.) email formats with LeadIQ.

HippoFi (Formerly ORHub, Inc.)

Q: What is HippoFi (Formerly ORHub, Inc.)'s NAICS code?

HippoFi (Formerly ORHub, Inc.)'s NAICS code is 3391 (Medical Equipment and Supplies Manufacturing).

Medical Equipment ManufacturingCalifornia, United States2-10 Employees

HippoFi, Inc. (formerly ORHub) is headquartered in Irvine, California. The Company is a healthcare innovator and fintech company focused on payment processes, business logistics, and clinical solutions with digital and biological technologies. The Company utilizes Intelligent Automation and Cellular based technologies to Change Business for Good and is comprised of three segments: FINTECH, BIOTECH, & ARTIFICIAL INTELLIGENCE:

With the acquisition of PUR Biologics, HippoFi's Regenerative Therapeutic division is focused on the sale of bone regenerative products, while targeting new areas of opportunity with patented cell-based technologies. 

Together, these solutions form a valuable foundation for new uses of AI and a mobile ecosystem for personalized patient centered information and accessibility.

Insights

Similar companies to HippoFi (Formerly ORHub, Inc.)

RLDatix

Streamline Health

EPIC Systems